Federal Funding Opportunities
Undertake research activities that would entail implementing and evaluating community-based efforts to fight the opioid overdose epidemic; Support and promote the partnership of law enforcement and public health agencies, whose collaboration is critical to reducing overdose and other harms of opioid(mis)use.
Agency: Office of National Drug Control Policy
FON: COOCLI1 
Amount: $4,500,000
Due Date: September 3, 2019
This Funding Opportunity Announcement (FOA) announces the availability of support for collaborative research by multi-disciplinary teams which is of high priority to NIDA and leads to synergistic outcomes based on the synthesis of multiple research approaches
Agency: National Institute on Drug Abuse (NIDA)
FOA: PAR-19-345
Amount: TBD
LOI Due: August 25, 2019
Due Date: September 25, 2019
The purpose of this Funding Opportunity Announcement (FOA) is to encourage developmental and exploratory research focused on determining the mechanisms for the variation in the prevalence of Opioid Use Disorder (OUD), and understanding and reducing disparities in opioid care in minority health and health disparity populations in the U.S. This initiative will also seek to identify multi-level intervention strategies at the institutional and systems level for addressing OUD in these populations.
Agency: National Institute of Health
FOA: PAR-18-745
Amount: $200,000
Due Date: November 14, 2019
The purpose of this FOA is to support one Multisite Clinical Center (MCC) to implement the enrollment and multimodal longitudinal assessment of a large cohort of EITHER an acute musculoskeletal trauma OR an acute peri-operative pain event patients to identify biosignatures for resilience to and/or the transition from acute to chronic pain.
Agency: National Institute of Neurological Disorders and Stroke (NINDS)
NO: NOT-AT-11-002
Amount: $3,400,000
Webinar: September 19, 2019
LOI Due: October 25, 2019
Due Date: November 26, 2019
NIDA Notice of Special Interest (NOSI)
The purpose of this Notice is to encourage the submission of research project applications that enhance our understanding of the nature, extent, distribution, etiology, comorbidities, and consequences of drug use, misuse, and addiction across individuals, families, communities, and diverse population groups.
NO: NOT-DA-19-066
Amount: Varies
Due Date: October 5, 2019

The National Institute on Drug Abuse ( NIDA ) is issuing this notice to encourage grant applications on the effects of changing cannabis laws and policies in the US and globally on public health, including exploring the impact of polysubstance use on health outcomes, including interactions (substitution/complementation) with alcohol, tobacco, and prescription and nonprescription opioids.
NO: NOT-DA-19-065
Amount: Varies
Due Date: October 5, 2019


The purpose of this Notice is to inform potential applicants to the National Institute on Drug Abuse ( NIDA ) of special interest in research to: 1) develop and test strategies to prevent the initiation of substance use, progression to substance use disorders, and to prevent substance use-related conditions such as HIV; 2) develop and test processes or strategies to implement, scale and sustain evidence-based prevention in community, practice, and service systems, with an emphasis on settings that may be opportune given the prevalence of at-risk individuals; and, 3) develop methods to conduct prevention science.
NO: NOT-DA-19-048
Amount: Varies
Due Date: October 5, 2019
The purpose of this Notice is to inform potential applications to the National Institute on Drug Abuse ( NIDA ) of special interest in grant applications to conduct rigorous health services and economic research to maximize the availability and delivery of efficient, effective drug, alcohol, and tobacco treatment and recovery support services. Examples of such research include: (1) clinical quality improvement; (2) quality improvement in services organization and management; (3) implementation science; (4) availability, demand, access, and financing; (5) effectiveness; and (6) development or improvement of research methodology, analytic approaches, and measurement instrumentation
NO: NOT-DA-19-037
Amount: Varies
Due Date: October 5, 2019
The purpose of this Notice is to inform potential applicants to the National Institute on Drug Abuse ( NIDA ) of special interest in research project applications studying the interplay of genetic and environmental factors in the onset, developmental trajectories, comorbidity, and outcomes of substance use disorders (SUDs).
NO: NOT-DA-19-038
Amount: Varies
Due Date: October 5, 2019
The purpose of this Notice is to inform potential applications to the National Institute on Drug Abuse ( NIDA ) to encourage grant applications that will use ‘big data’ analytics to reveal deeper or novel insights into the biological and behavioral processes associated with substance use and addiction by developing more powerful analytical methods and visualization tools that can help capture the richness of different data types and across scales of analysis; including molecular, clinical, and electronic health records. Applications should develop and/or utilize computational approaches for analyzing large, complex datasets acquired from drug addiction research.
NO: NOT-DA-19-041
Amount: Varies
Due Date: October 5, 2019
To encourage basic science research aimed at enhancing our ability to prevent or treat opioid abuse, overdose, addiction and/or relapse.
NIDA welcomes applications studying diverse aspects of opioid use including, but not limited to:
• Genetics and epigenetics related to opioid use disorder vulnerability
• Opioid receptor structure, chemistry and pharmacology
• Opioid-induced cellular and circuit plasticity that may influence vulnerability to tolerance, physical dependence, addiction or relapse or determine the trajectory to recovery
• Behavioral and/or environmental determinants of the consequences of opioid administration.
NO: DAT18-07
Amount: Varies
Due Date: Varies
To encourage research project submissions examining the molecular, cellular, circuit, and behavioral responses to neuroimmune signaling in the CNS in relation to: the trajectory (i.e. initiation, escalation, and maintenance) of drug misuse; consequences of chronic exposure to misused drugs; abstinence and withdrawal from prolonged use; and relapse or reinstatement of drug taking.
NO: DAT18-01
Amount: Varies
Due Date: Varies
To encourage the submission of research project applications for: 1) development and testing of interventions and strategies to prevent the initiation of substance use, the progression to substance use disorders, and the spread of substance use-related conditions such as HIV and viral hepatitis; 2) development and testing of processes or strategies for the adoption, sustainability, and scalability of science-based prevention in community, practice, and service systems; and, 3) development of methods to study complex aspects of prevention research.
NO: DAT18-02
Amount: Varies
Due Date: Varies
To encourage research project applications to study of effects and functional consequences of cannabis and cannabinoid exposure on the developing brain, from pre-, peri-, and post-natal development through young adulthood in animal models and humans.Including : Changes in brain structure and activity as a function of cannabis/cannabinoid use, alone or in conjunction with other abused substances (i.e. nicotine, opioids, alcohol).
NO: DAT18-04
Amount: Varies
Due Date: Varies
To encourage research on the effects of maternal opioid (agonist or antagonist) exposure on embryonic, fetal, and post-natal brain and behavioral development, and other health outcomes, and the mechanisms underlying these effects.
NO: DAT18-08
Amount: Varies
Due Date: Varies
SEPTEMBER IS RECOVERY MONTH!

September is National Recovery Month. All Brigham and Women's Hospital and Brigham and Women's Faulkner Hospital faculty and staff are invited to participate in several recovery awareness events, created to celebrate recovery and educate our community on the Brigham Health services available to those in need.

OPIOID USE DISORDER CARE IN PRIMARY CARE
In celebration of Recovery Month and primary care’s role in addiction care, Harvard's Center for Primary Care is featuring a podcast show about caring for patients with addiction.
Guests this week are Adele Ojeda, the office based opioid treatment nurse for Barre Family Health Center and Dr. Stephen Martin, Center faculty member, Associate Professor of Family Medicine and Community Health at University of Massachusetts Medical School and a faculty physician.



Interested in learning more about opioid use disorder in primary care? Click Link above for information on the 2019 Primary Care Conference, October 5, 2019. Sessions cover topics like opioids and integrating mental health within primary care, frameworks for decisions about integrating behavioral health in primary care practices, and more!

Featured Innovator Publications
Brian T. Bateman, MD - Anesthesiology Perioperative and Pain Medicine
Days' Supply of Initial Opioid Analgesic Prescriptions and Additional Fills for Acute Pain Conditions Treated in the Primary Care Setting - Feb, 2019


Inappropriate Opioid Prescription After Surgery - April, 2019

Mieke A. Soens, MD; Brian T. Bateman, MD - Anesthesiology Perioperative and Pain Medicine
Anesthesia Considerations and Post-Operative Pain Management in Pregnant Women with Chronic Opioid Use.- April, 2019

Joji Suzuki, MD - Psychiatry 
The “White Powder Sign” for Substance Use in Hospitalized Patients - April, 2019

Philipp Lirk, M.D.,M.Sc.,Ph.D. - Anesthesiology Perioperative and Pain Medicine
Pain Management After Laparoscopic Hysterectomy: Systematic Review of Literature and PROSPECT Recommendations. - April, 2019

Kristin Schreiber, MD, PhD - Anesthesiology Perioperative and Pain Medicine
Preoperative Psychosocial and Psychophysical Phenotypes as Predictors of Acute Pain Outcomes After Breast Surgery - May, 2019


Benefit of Regional Anaesthesia on Postoperative Pain Following Mastectomy: the Influence of Catastrophising. - August, 2019

Kamen V. Vlassakov, MD - Anesthesiology Perioperative and Pain Medicine
The Ultrasound-Guided Proximal Intercostal Block: Anatomical Study and Clinical Correlation to Analgesia for Breast Surgery - June, 2019

Elizabeth G. Matzkin, MD - Orthopedics 
Patient Satisfaction With Nonopioid Pain Management Following Arthroscopic Partial Meniscectomy and/or Chondroplasty. - June, 2019

Seoyoung Kim MD, ScD,- Rheumatology, Immunology and Allergy
Patterns of Prescription Opioid Use Before Total Hip and Knee Replacement Among US Medicare Enrollees - June, 2019



MARK YOUR CALENDARS!!!

The next Opioid and Pain Innovator Meeting will be held
Thursday, September 25, 2019

If you would like to attend please RSVP to the right.

For any additional questions or concerns contact Gloria Brand, Senior Program Manager
Opioid and Pain Innovation Program
617-278-0516

Opioid and Pain Innovator Meeting
LOCATION
Hale BTM room 05010 or Zoom

DATE AND TIME
09/25/19 4:00am - 09/25/19 5:00pm

One person in the group will present their research or ideas for 20-30 minutes, and we will review OPI program and network.
I'll be there!
Maybe
I can't make it